Faron’s Financial Calendar for 2024
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
TURKU, FINLAND / BOSTON, MA - December 22, 2023 - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on tackling difficult-to-treat cancers and inflammation via precision immunotherapy, today announces the following dates for the Company's financial reporting in 2024:
| February 2 9 | Financial statement release for the full year 202 3 and Annual Report 202 3 including financial statements for the full year |
| August 2 7 | Half-year financial report for the period January 1 to June 30, 202 4 |
The annual general meeting is planned to be held on March 22, 2024. A separate stock exchange notice will be issued by Faron's Board of Directors to convene the meeting.
About Faron Pharmaceuticals Ltd.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.